Option Care Health (NASDAQ:OPCH) Posts Quarterly Earnings Results, Beats Expectations By $0.04 EPS

Option Care Health (NASDAQ:OPCH) posted its earnings results on Tuesday. The company reported $0.26 earnings per share for the quarter, beating the consensus estimate of $0.22 by $0.04, Briefing.com reports. The firm had revenue of $1.15 billion during the quarter, compared to the consensus estimate of $1.10 billion. Option Care Health had a net margin of 6.15% and a return on equity of 18.92%. The firm’s revenue for the quarter was up 12.8% on a year-over-year basis. During the same period last year, the firm posted $0.21 EPS. Option Care Health updated its FY 2024 guidance to EPS.

Option Care Health Price Performance

Shares of NASDAQ:OPCH traded up $0.37 during midday trading on Friday, reaching $29.66. The company’s stock had a trading volume of 109,293 shares, compared to its average volume of 1,276,048. The business’s fifty day simple moving average is $32.04 and its 200-day simple moving average is $31.50. The company has a market capitalization of $5.16 billion, a P/E ratio of 19.27, a P/E/G ratio of 1.65 and a beta of 1.22. Option Care Health has a fifty-two week low of $24.23 and a fifty-two week high of $35.74. The company has a debt-to-equity ratio of 0.74, a current ratio of 1.77 and a quick ratio of 1.33.

Wall Street Analysts Forecast Growth

A number of analysts have recently issued reports on the stock. Jefferies Financial Group lifted their price objective on shares of Option Care Health from $36.00 to $38.00 and gave the company a “buy” rating in a research note on Monday, March 4th. Barrington Research reissued an “outperform” rating and set a $38.00 price target on shares of Option Care Health in a report on Wednesday.

Insider Activity at Option Care Health

In other news, Director Harry M. Jansen Kraemer, Jr. bought 35,000 shares of the company’s stock in a transaction that occurred on Monday, February 26th. The shares were acquired at an average price of $31.55 per share, with a total value of $1,104,250.00. Following the transaction, the director now owns 269,528 shares in the company, valued at $8,503,608.40. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. 0.64% of the stock is owned by company insiders.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.